Amedeo Smart

Free Medical Literature Service


 

Amedeo

Hepatitis C

  Free Subscription

22.08.2022

1 Am J Gastroenterol
1 Clin Res Hepatol Gastroenterol
1 Hepatology
1 J Gen Virol
1 PLoS One



    Am J Gastroenterol

  1. CALVARUSO V, Celsam C, D'Ambrosio R, Simone F, et al
    RESIST-HCV criteria to monitor progression of low-risk esophageal varices in patients with compensated cirrhosis after HCV eradication. The SIMPLE study: SIMPLE: Scoring Index to Monitor Progression of Low-risk Esophageal varices.
    Am J Gastroenterol. 2022 Jun 17. pii: 00000434-990000000-00413.
    >> Share


    Clin Res Hepatol Gastroenterol

  2. YANG X, Wang N, Li S, Gu Y, et al
    No differences in the risk of Hepatocellular Carcinoma from Using Direct-Acting Antiviral Agents or Interferon in Patients with Chronic Hepatitis C: A meta-analysis.
    Clin Res Hepatol Gastroenterol. 2022 Aug 12:102001.
    >> Share


    Hepatology

  3. LOUREIRO D, Tout I, Narguet S, Bed CM, et al
    Mitochondrial stress in advanced fibrosis and cirrhosis associated with chronic hepatitis B, chronic hepatitis C or nonalcoholic steatohepatitis.
    Hepatology. 2022 Aug 16. doi: 10.1002/hep.32731.
    >> Share


    J Gen Virol

  4. NEUFELDT CJ, Cortese M
    Membrane architects: how positive-strand RNA viruses restructure the cell.
    J Gen Virol. 2022;103.
    >> Share


    PLoS One

  5. LU YH, Lu CK, Chen CH, Hsieh YY, et al
    Comparison of 8- versus 12-weeks of glecaprevir/pibrentasvir for Taiwanese patients with hepatitis C and compensated cirrhosis in a real-world setting.
    PLoS One. 2022;17:e0272567.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016